Could a quicker switch to stronger meds beat bipolar depression?

NCT ID NCT05973786

Recruiting now Disease control Sponsor: Dr. Inge Winter Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether quickly switching to a more intensive combination of medications helps people with bipolar depression who didn't get better on their first treatment. About 418 adults will either receive standard care or an intensified regimen of antidepressants and mood stabilizers for six weeks. The goal is to see if this approach leads to greater improvement in depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

a combination of antidepressants (escitalopram, sertraline, venlafaxine, bupropion) and mood stabilizers (lithium, valproate, quetiapine)

What this could lead to

If successful, this could provide a clear treatment strategy for people with bipolar depression who don't respond to their first medication, potentially reducing suffering and improving daily life.

What could go wrong

This is a phase 3 trial, but it's still testing a strategy rather than a new drug. The benefits may be modest, and some participants may experience side effects from the medications. Results may not apply to everyone with bipolar depression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar depression bipolar disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DEPRESSION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda Ospedaliero-Universitaria "Città della Salute e della Scienza di Torino"
RECRUITING

Turin, Italy

Contact Email: •••••@•••••
Eginition hospital, department of psychiatry
NOT_YET_RECRUITING

Athens, 11528, Greece

Contact Email: •••••@•••••
Fundació Clínic per a la Recerca Biomèdica
RECRUITING

Barcelona, Spain

Contact Email: •••••@•••••
King's College London, Psychiatry & Cognitive Neuroscience
NOT_YET_RECRUITING

London, SE5 8AF, United Kingdom

Contact Email: •••••@•••••

Contact Email: •••••@•••••
Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz
RECRUITING

Mainz, Germany

Contact Email: •••••@•••••
LWL-Klinik Dortmund, Bereich Forschung & Wissenschaft
RECRUITING

Dortmund, 44287, Germany

Contact Email: •••••@•••••
Medical University Innsbruck
RECRUITING

Innsbruck, Austria

Contact Email: •••••@•••••
Universita degli Studi di Brescia
RECRUITING

Brescia, Italy

Contact Email: •••••@•••••
University Hospital Frankfurt am Main - Goethe University
RECRUITING

Frankfurt am Main, Germany

Contact Email: •••••@•••••
University of Cagliari
RECRUITING

Cagliari, Italy

Contact Email: •••••@•••••
Università degli studi della Campania Luigi Vanvitelli
RECRUITING

Naples, 80138, Italy

Contact Email: •••••@•••••
Universitätsklinik für Psychiatrie und Psychotherapie Bielefeld
RECRUITING

Bielefeld, Germany

Contact Email: •••••@•••••
Westfälische Wilhelms-Universität Münster
RECRUITING

Münster, Germany

Contact Email: •••••@•••••